These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 8146731

  • 1. [Effects of combined administration of prednisolone and mizoribine in the course of remission for SLE children with nephritis].
    Aihara Y, Ibe M, Mitsuda T, Mori M, Shimizu C, Takahashi Y, Kuriyama T, Yokota S.
    Ryumachi; 1994 Feb; 34(1):64-70. PubMed ID: 8146731
    [Abstract] [Full Text] [Related]

  • 2. A case of lupus nephritis improved after appropriately adjusting the dosage of mizoribine.
    Tsubouchi Y, Fukuda W, Kawahito Y, Kohno M, Wada M, Ishino H, Hamaguchi M, Yamamoto A, Kadoya M, Niimi M, Yoshikawa T.
    Mod Rheumatol; 2008 Feb; 18(1):91-5. PubMed ID: 18159569
    [Abstract] [Full Text] [Related]

  • 3. Mizoribine for the treatment of lupus nephritis in children and adolescents.
    Tanaka H, Tsugawa K, Tsuruga K, Suzuki K, Nakahata T, Ito E, Waga S.
    Clin Nephrol; 2004 Dec; 62(6):412-7. PubMed ID: 15630899
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of mizoribine in the treatment of systemic lupus erythematosus in children.
    Yoshidome K, Takei S, Imanaka H, Maeno N, Ohkawa T, Kawano Y.
    Pediatr Int; 2004 Aug; 46(4):444-9. PubMed ID: 15310311
    [Abstract] [Full Text] [Related]

  • 5. Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.
    Yumura W, Suganuma S, Uchida K, Moriyama T, Otsubo S, Takei T, Naito M, Koike M, Nitta K, Nihei H.
    Clin Nephrol; 2005 Jul; 64(1):28-34. PubMed ID: 16047642
    [Abstract] [Full Text] [Related]

  • 6. [Improvement of the maintenance therapy after methylprednisolone pulse therapy--effect of prednisolone combined with immunosuppressants].
    Miyamae T, Nakasima S, Imagawa T, Ito S, Katakura S, Tomono N, Mori M, Ibe M, Mitsuda T, Aihara Y, Yokota S.
    Ryumachi; 1999 Dec; 39(6):829-35. PubMed ID: 10695406
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of multitarget therapy with mizoribine and tacrolimus for systemic lupus erythematosus with or without active nephritis.
    Nomura A, Shimizu H, Kishimoto M, Suyama Y, Rokutanda R, Ohara Y, Yamaguchi K, Okada M.
    Lupus; 2012 Nov; 21(13):1444-9. PubMed ID: 22917589
    [Abstract] [Full Text] [Related]

  • 8. Combination therapy with steroids and mizoribine in juvenile SLE: a randomized controlled trial.
    Tanaka Y, Yoshikawa N, Hattori S, Sasaki S, Ando T, Ikeda M, Honda M, Japanese Study Group for Renal Disease in Children.
    Pediatr Nephrol; 2010 May; 25(5):877-82. PubMed ID: 19902267
    [Abstract] [Full Text] [Related]

  • 9. Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis.
    Tanaka H, Tsugawa K, Suzuki K, Nakahata T, Ito E.
    Pediatr Nephrol; 2006 Jul; 21(7):962-6. PubMed ID: 16773408
    [Abstract] [Full Text] [Related]

  • 10. Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patients.
    Tanaka H, Tsugawa K, Oki E, Suzuki K, Ito E.
    Clin Rheumatol; 2008 Jan; 27(1):85-9. PubMed ID: 17483980
    [Abstract] [Full Text] [Related]

  • 11. High-dose mizoribine treatment for adolescents with systemic lupus erythematosus.
    Nozu K, Iijima K, Kamioka I, Fujita T, Yoshiya K, Tanaka R, Nakanishi K, Yoshikawa N, Matsuo M.
    Pediatr Int; 2006 Apr; 48(2):152-7. PubMed ID: 16635174
    [Abstract] [Full Text] [Related]

  • 12. Mizoribine as an effective combined maintenance therapy with prednisolone in child-onset systemic lupus erythematosus.
    Aihara Y, Miyamae T, Ito S, Kobayashi S, Imagawa T, Mori M, Ibe M, Mitsuda T, Yokota S.
    Pediatr Int; 2002 Apr; 44(2):199-204. PubMed ID: 11896887
    [Abstract] [Full Text] [Related]

  • 13. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
    Hama T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Sako M, Saito-Oba M, Nozu K, Shima Y, Iijima K, Yoshikawa N, Japanese Study Group of Kidney Disease in Children (JSKDC).
    BMC Nephrol; 2018 Sep 10; 19(1):223. PubMed ID: 30200895
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of mizoribine-tacrolimus-based induction therapy for pediatric lupus nephritis.
    Tanaka H, Aizawa T, Watanabe S, Oki E, Tsuruga K, Imaizumi T.
    Lupus; 2014 Jul 10; 23(8):813-8. PubMed ID: 24651669
    [Abstract] [Full Text] [Related]

  • 15. Implication of the peak serum level of mizoribine for control of the serum anti-dsDNA antibody titer in patients with lupus nephritis.
    Tanaka H, Tsugawa K, Nakahata T, Kudo M, Suzuki K, Ito E.
    Clin Nephrol; 2005 Jun 10; 63(6):417-22. PubMed ID: 15960142
    [Abstract] [Full Text] [Related]

  • 16. [Two cases of lupus cystitis complicated by lupus nephritis treated successfully with steroid therapy].
    Obayashi M, Uzu T, Harada T, Yamato M, Takahara K, Yamauchi A.
    Nihon Jinzo Gakkai Shi; 2003 Jun 10; 45(8):765-70. PubMed ID: 14737994
    [Abstract] [Full Text] [Related]

  • 17. Pediatric lupus nephritis: more options, more chances?
    Vachvanichsanong P, McNeil E.
    Lupus; 2013 May 10; 22(6):545-53. PubMed ID: 23629826
    [Abstract] [Full Text] [Related]

  • 18. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
    Roccatello D, Sciascia S, Rossi D, Alpa M, Naretto C, Baldovino S, Menegatti E, La Grotta R, Modena V.
    Nephrol Dial Transplant; 2011 Dec 10; 26(12):3987-92. PubMed ID: 21385860
    [Abstract] [Full Text] [Related]

  • 19. [A case of systemic lupus erythematosus (SLE) successfully treated with mizoribine (Bredinin)].
    Iwasaki T, Hamano T, Aizawa K, Kobayashi K, Kakishita E.
    Ryumachi; 1994 Oct 10; 34(5):885-9. PubMed ID: 7801201
    [Abstract] [Full Text] [Related]

  • 20. Mizoribine treatment of young patients with severe lupus nephritis: a clinicopathologic study by the tohoku pediatric study group.
    Tanaka H, Oki E, Tsuruga K, Sato N, Matsukura H, Matsunaga A, Kondo Y, Suzuki J.
    Nephron Clin Pract; 2008 Oct 10; 110(2):c73-9. PubMed ID: 18758186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.